A comparison of etodolac (Ultradol®) with acetaminophen plus codeine (Tylenol #3) in controlling post-surgical pain in vasectomy patients

References

• Humber L. G. Etodolac (Lodine®), the first NSAID of the pyranocarboxylic acid class: A review of preclinical and clinical studies through 1992. Drugs of Today 1993; 29: 265, 2931. Humber L. G. Etodolac (Lodine®), the first NSAID of the pyranocarboxylic acid class: A review of preclinical and clinical studies through 1992. Drugs of Today 1993; 29: 265, 293
   Google Scholar
• Martel R., Klicius J. Anti-inflammatory and analgesic properties of etodolac in rats. Can. J. Physiol. Pharmacol. 1976; 54: 245, 2472. Martel R., Klicius J. Anti-inflammatory and analgesic properties of etodolac in rats. Can. J. Physiol. Pharmacol. 1976; 54: 245, 247
   PubMed Web of Science ®Google Scholar
• Bacon P. A. An overview of the efficacy of etodolac in arthritic disorders. Eur. J. Rheumatol. Inflamm. 1990; 10: 22, 343. Bacon P. A. An overview of the efficacy of etodolac in arthritic disorders. Eur. J. Rheumatol. Inflamm. 1990; 10: 22, 34
   PubMedGoogle Scholar
• Pena M. Etodolac: analgesic effects in musculoskeletal and postoperative pain. Rheumatol. Int. 1990; 10: 9–16, Suppl.4. Pena M. Etodolac: analgesic effects in musculoskeletal and postoperative pain. Rheumatol. Int. 1990; 10: 9–16, Suppl.
   PubMed Web of Science ®Google Scholar
• Gaston G. N., Mallow R. D., Frank J. E. The efficacy of etodolac compared with aspirin and placebo in patients with pain following oral surgery. J. Oral. Maxillofacial Surg. 1989; 42: 362, 3665. Gaston G. N., Mallow R. D., Frank J. E. The efficacy of etodolac compared with aspirin and placebo in patients with pain following oral surgery. J. Oral. Maxillofacial Surg. 1989; 42: 362, 366
   Google Scholar
• Nelson S. L., Bergman S. A. Relief of dental surgery pain: a controlled 12-hour comparison of etodolac, aspirin, and placebo. Anesth. Prog. 1985; 151–156, Jul/Aug6. Nelson S. L., Bergman S. A. Relief of dental surgery pain: a controlled 12-hour comparison of etodolac, aspirin, and placebo. Anesth. Prog. 1985; 151–156, Jul/Aug
   PubMedGoogle Scholar
• Fliedner L., Levsky M., Kechejian H. Analgesia with etodolac in oral postsurgical pain. Curr. Thev. Rex 1984; 36: 33, 457. Fliedner L., Levsky M., Kechejian H. Analgesia with etodolac in oral postsurgical pain. Curr. Thev. Rex 1984; 36: 33, 45
   Web of Science ®Google Scholar
• Friedrich E. A comparison of etodolac (Ultradol®) with aspirin and placebo in patients with episiotomy pain. Curr. Ther. Res. 1983; 33: 100, 1078. Friedrich E. A comparison of etodolac (Ultradol®) with aspirin and placebo in patients with episiotomy pain. Curr. Ther. Res. 1983; 33: 100, 107
   Web of Science ®Google Scholar
• Versichelen L., Bilsback P., Roily G. Etodolac in post-surgical pain: double-blind dose-ranging efficacy study with aspirin and placebo. Int. J. Clin. Pharmacol. Ther. Toxicol. 1983; 20: 236, 2399. Versichelen L., Bilsback P., Roily G. Etodolac in post-surgical pain: double-blind dose-ranging efficacy study with aspirin and placebo. Int. J. Clin. Pharmacol. Ther. Toxicol. 1983; 20: 236, 239
   Google Scholar
• Glaser K., Sung M. L., O'Neill K. Etodolac selectively inhibits prosta-glandin G/H/synthase 2 (PGHS-2) versus human PGHS-1. Eur. J. Pharm. 1995; 281: 107, 11110. Glaser K., Sung M. L., O'Neill K. Etodolac selectively inhibits prosta-glandin G/H/synthase 2 (PGHS-2) versus human PGHS-1. Eur. J. Pharm. 1995; 281: 107, 111
   Web of Science ®Google Scholar
• Dvornik D., Lee D. K. H. Theoretical mechansims for the gastrointestinal safety of etodolac: selective sparing of cytoprotective prostaglandins. Clin. Rheumatol. 1989; 8: 16, 2411. Dvornik D., Lee D. K. H. Theoretical mechansims for the gastrointestinal safety of etodolac: selective sparing of cytoprotective prostaglandins. Clin. Rheumatol. 1989; 8: 16, 24
   PubMed Web of Science ®Google Scholar
• Lee D., Dvornik D. Etodolac: Effect on prostaglandin concentrations in gastric mucosa of rats. Life Sci. 1985; 36: 1157, 116212. Lee D., Dvornik D. Etodolac: Effect on prostaglandin concentrations in gastric mucosa of rats. Life Sci. 1985; 36: 1157, 1162
   PubMed Web of Science ®Google Scholar
• Lee D. K. H., Cohen R., Gilliar J. A subchronic study of the effects of etodolac on the gastric mucosa prostaglandin levels in the rat. Agents Actions 1986; 19: 228, 23213. Lee D. K. H., Cohen R., Gilliar J. A subchronic study of the effects of etodolac on the gastric mucosa prostaglandin levels in the rat. Agents Actions 1986; 19: 228, 232
   PubMedGoogle Scholar
• Taha A. S., McLaughlin S., Holland P. J. Effect on gastric and duodenal mucosal prostaglandins of repeated intake of therapeutic doses of naproxen and etodolac in rheumatoid arthritis. Ann. Rheum. Dis. 1990; 49: 354, 35814. Taha A. S., McLaughlin S., Holland P. J. Effect on gastric and duodenal mucosal prostaglandins of repeated intake of therapeutic doses of naproxen and etodolac in rheumatoid arthritis. Ann. Rheum. Dis. 1990; 49: 354, 358
   PubMed Web of Science ®Google Scholar
• Hutton C. The effectiveness of 100 and 200 mg etodolac, aspirin, and placebo in patients with pain following oral surgery. Oral Surg. 1983; 56: 575, 58015. Hutton C. The effectiveness of 100 and 200 mg etodolac, aspirin, and placebo in patients with pain following oral surgery. Oral Surg. 1983; 56: 575, 580
   Google Scholar
• McCormack M., LaPointe S. Physiological consequences and complications of vasectomy. Can. Med. Assoc. J. 1985; 138: 223, 22516. McCormack M., LaPointe S. Physiological consequences and complications of vasectomy. Can. Med. Assoc. J. 1985; 138: 223, 225
   Google Scholar
• Manson A. L. Trial of ibuprofen to prevent post-vasectomy complications. J. Urol. 1988; 139: 965, 96617. Manson A. L. Trial of ibuprofen to prevent post-vasectomy complications. J. Urol. 1988; 139: 965, 966
   PubMed Web of Science ®Google Scholar
• Gaston G. W., Mallow R. D., Frank J. E. The efficacy of etodolac for patients with pain following oral surgery. J. Oral Maxillofac. Surg. 1984; 42: 362, 36618. Gaston G. W., Mallow R. D., Frank J. E. The efficacy of etodolac for patients with pain following oral surgery. J. Oral Maxillofac. Surg. 1984; 42: 362, 366
   PubMed Web of Science ®Google Scholar
• D'Hooglie M. Double-blind, parallel-group evaluation of etodolac and naproxen in patients with acute sports injuries. Clin. Ther. 1992; 14: 507, 51619. D'Hooglie M. Double-blind, parallel-group evaluation of etodolac and naproxen in patients with acute sports injuries. Clin. Ther. 1992; 14: 507, 516
   PubMed Web of Science ®Google Scholar
• Mizraji M. Clinical response to etodolac in the management of pain. Eur. J. Rheumatol. Inflamm. 1990; 10: 35, 4120. Mizraji M. Clinical response to etodolac in the management of pain. Eur. J. Rheumatol. Inflamm. 1990; 10: 35, 41
   PubMedGoogle Scholar
• Beaver W. T. Impact of non-narcotic oral analgesics on pain management. Am. J. Med. 1988; 84: 3, 1521. Beaver W. T. Impact of non-narcotic oral analgesics on pain management. Am. J. Med. 1988; 84: 3, 15
   PubMed Web of Science ®Google Scholar
• Brune K. The pharmacological profile of non-opioid (OTC) analgesics: Aspirin, paracetamol (acetaminophen), ibuprofen. and phenazones. Agents Actions Suppl. 1988; 25: 9, 1922. Brune K. The pharmacological profile of non-opioid (OTC) analgesics: Aspirin, paracetamol (acetaminophen), ibuprofen. and phenazones. Agents Actions Suppl. 1988; 25: 9, 19
   PubMedGoogle Scholar
• Kacso G., Terezhalmy G. T. Acetylsalicylic acid and acetaminophen. Dent. Clin. North Am. 1994; 38: 633, 64423. Kacso G., Terezhalmy G. T. Acetylsalicylic acid and acetaminophen. Dent. Clin. North Am. 1994; 38: 633, 644
   PubMedGoogle Scholar
• Rummans T. A. Nonopioid agents for treatment of acute and subacute pain. Mayo Clin. Proc. 1994; 69: 481–49024. Rummans T. A. Nonopioid agents for treatment of acute and subacute pain. Mayo Clin. Proc. 1994; 69: 481–490
   PubMed Web of Science ®Google Scholar
• Compendium of Pharmaceuticals and Specialties 31st edition, M. C. Gillis. Canadian Pharmaceutical Association, Ottawa 1996; 1535, 1538, Ed.25. Compendium of Pharmaceuticals and Specialties 31st edition, M. C. Gillis. Canadian Pharmaceutical Association, Ottawa 1996; 1535, 1538, Ed.
   Google Scholar